en

PRODUCT DETAIL

Glezisim 10 mg/20 mg tablety

Code 9001C
MA number 31/0309/18-S
Product Form: tbl 300x10 mg/20 mg (blis.PVC/Al/OPA/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10B Lipid modifying agents, combinations
C10BA Combinations of various lipid modifying agents
C10BA02 Simvastatin and ezetimibe
Shelf life: 24
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 20.09.2018
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Glezisim tablety_10.2023.pdf  
SPC: SPC_Glezisim tablety_10.2023.pdf  
Safety feature Yes
Data update: 16.10.2023
eu-flag.png sk-flag.png